P1740: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IDECABTAGENE VICLEUCEL VS BELANTAMAB MAFODOTIN: A MATCHING-ADJUSTED INDIRECT COMPARISON STUDY

• N. Shah,
• D. Ayers,
• S. Cope,
• K. Karampampa,
• K. Towle,
• J. Braverman,
• A. Mojebi,
• C. Caisip,
• D. Dhanda

Affiliations

N. Shah

1 University of California San Francisco, San Francisco, CA, United States of America

D. Ayers

2 PRECISIONheor, Vancouver, BC, Canada

S. Cope

2 PRECISIONheor, Vancouver, BC, Canada

K. Karampampa

3 Bristol Myers Squibb, Princeton, NJ, United States of America

K. Towle

2 PRECISIONheor, Vancouver, BC, Canada

J. Braverman

3 Bristol Myers Squibb, Princeton, NJ, United States of America

A. Mojebi

2 PRECISIONheor, Vancouver, BC, Canada

C. Caisip

2 PRECISIONheor, Vancouver, BC, Canada

D. Dhanda

3 Bristol Myers Squibb, Princeton, NJ, United States of America